Placebo Response Uncontrolled trials took a bad knock from the crisp paper by Epstein,7 who compared the effects of four sorts of tablets on itchy patients. About twothirds of his patien-ts were helped by one or more of the tablets. All four were, in fact, placebos, so any benefit must be shown to be more than a placebo would give. In a double blind trial3 neither trimeprazine nor cyproheptadine, both widely used for itching, did any better than the placebo they were up against.
Another fallacy, in some trials of antihistamines, is the way the various itchy diseases, including urticaria, have been lumped together; urticaria may be expected to do well with antihistamines and the results must be falsely impressive.
Some general rules come out of these studies. 
Specific Measures
If ithe underlying cause is known, its treatment may cure the associated itch. In onchocerciasis, for example, after a brief flare-up-reliable enough to be used as a diagnostic testthe itch subsides when diethylcarbamazine is used. T,he itching and urticarial lesions which may go with thyrotoxicosis will settle with antithyroid treatment.9 If an obstructive jaundice can be corrected surgically the accompanying itching will settle.
A cure is not always so simple, however-for example, the itching associated with chronic renal failure is not always reliably helped by dialysis, though parathyroidectomy has been reported to be helpful, the itch subsiding within a few days of -the operation. In liver disease which cannot be improved surgically synthetic androgens may -be some help, though they may actually deepen the jaundice. Cholestyramiine, a basic anion exchange resin, binds bile salts in the intestine and may relieve the itching of partial biliary obstruction, but in the doses used (10-16 g daily) is unpleasan-t to take.
